{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:20:23Z","timestamp":1787678423649,"version":"build-2784847793"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"25","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2001,6,26]]},"abstract":"<jats:p><jats:italic>Background<\/jats:italic>\u2014<jats:italic>N<\/jats:italic>-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) is a natural inhibitor of pluripotent hematopoietic stem cell proliferation. Ac-SDKP plasma concentration is increased 5-fold after angiotensin-converting enzyme inhibition. Here we studied the effect of Ac-SDKP on monocyte\/macrophage infiltration, fibroblast proliferation, and collagen deposition in the rat heart in renovascular hypertension.<\/jats:p><jats:p><jats:italic>Methods and Results<\/jats:italic>\u2014We investigated whether long-term Ac-SDKP administration would prevent left ventricular (LV) hypertrophy and interstitial collagen deposition in rats with 2-kidney, 1-clip (2K-1C) hypertension. Ac-SDKP (400 \u03bcg \u00b7 kg<jats:sup>\u22121<\/jats:sup>\u00b7 d<jats:sup>\u22121<\/jats:sup>) did not affect development of hypertension. Mean blood pressure was similar in rats with 2K-1C hypertension whether they were given vehicle or Ac-SDKP and was higher than in controls. Both LV weight and cardiomyocyte size were significantly increased in rats with 2K-1C hypertension compared with controls and were unaffected by Ac-SDKP. Proliferating cell nuclear antigen- and monocyte\/macrophage-positive cells were increased in the LV of 2K-1C hypertensive rats; this increase was significantly blunted by Ac-SDKP (<jats:italic>P<\/jats:italic>&lt;0.001). LV interstitial collagen fraction was also increased in 2K-1C hypertensive rats given vehicle (10.1\u00b10.8%) compared with sham (5.3\u00b10.1%,<jats:italic>P<\/jats:italic>&lt;0.0001), and this increase was prevented by Ac-SDKP (5.4\u00b10.4%,<jats:italic>P<\/jats:italic>&lt;0.001).<\/jats:p><jats:p><jats:italic>Conclusions<\/jats:italic>\u2014Ac-SDKP inhibited monocyte\/macrophage infiltration, cell proliferation, and collagen deposition in the LV of hypertensive rats without affecting blood pressure or cardiac hypertrophy, suggesting that it may be partly responsible for the cardioprotective effect of angiotensin-converting enzyme inhibitors.<\/jats:p>","DOI":"10.1161\/01.cir.103.25.3136","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:09:32Z","timestamp":1339459772000},"page":"3136-3141","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":54,"title":["Long-Term Effect of<i>N<\/i>-Acetyl-Seryl-Aspartyl-Lysyl-Proline on Left Ventricular Collagen Deposition in Rats With 2-Kidney, 1-Clip Hypertension"],"prefix":"10.1161","volume":"103","author":[{"given":"Nour-Eddine","family":"Rhaleb","sequence":"first","affiliation":[{"name":"From the Hypertension and Vascular Research Division (N.-E.R., H.P., X.-P.Y., Y.-H.L., D.M., O.A.C.), Henry Ford Hospital, Detroit, Mich, and CEA (E.E.), Service de Pharmacologie et d\u2019Immunologie, Saclay, Gif-sur-Yvette, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Peng","sequence":"additional","affiliation":[{"name":"From the Hypertension and Vascular Research Division (N.-E.R., H.P., X.-P.Y., Y.-H.L., D.M., O.A.C.), Henry Ford Hospital, Detroit, Mich, and CEA (E.E.), Service de Pharmacologie et d\u2019Immunologie, Saclay, Gif-sur-Yvette, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ping","family":"Yang","sequence":"additional","affiliation":[{"name":"From the Hypertension and Vascular Research Division (N.-E.R., H.P., X.-P.Y., Y.-H.L., D.M., O.A.C.), Henry Ford Hospital, Detroit, Mich, and CEA (E.E.), Service de Pharmacologie et d\u2019Immunologie, Saclay, Gif-sur-Yvette, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-He","family":"Liu","sequence":"additional","affiliation":[{"name":"From the Hypertension and Vascular Research Division (N.-E.R., H.P., X.-P.Y., Y.-H.L., D.M., O.A.C.), Henry Ford Hospital, Detroit, Mich, and CEA (E.E.), Service de Pharmacologie et d\u2019Immunologie, Saclay, Gif-sur-Yvette, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmesh","family":"Mehta","sequence":"additional","affiliation":[{"name":"From the Hypertension and Vascular Research Division (N.-E.R., H.P., X.-P.Y., Y.-H.L., D.M., O.A.C.), Henry Ford Hospital, Detroit, Mich, and CEA (E.E.), Service de Pharmacologie et d\u2019Immunologie, Saclay, Gif-sur-Yvette, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Ezan","sequence":"additional","affiliation":[{"name":"From the Hypertension and Vascular Research Division (N.-E.R., H.P., X.-P.Y., Y.-H.L., D.M., O.A.C.), Henry Ford Hospital, Detroit, Mich, and CEA (E.E.), Service de Pharmacologie et d\u2019Immunologie, Saclay, Gif-sur-Yvette, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar A.","family":"Carretero","sequence":"additional","affiliation":[{"name":"From the Hypertension and Vascular Research Division (N.-E.R., H.P., X.-P.Y., Y.-H.L., D.M., O.A.C.), Henry Ford Hospital, Detroit, Mich, and CEA (E.E.), Service de Pharmacologie et d\u2019Immunologie, Saclay, Gif-sur-Yvette, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(90)81322-F"},{"key":"e_1_3_2_2_2","first-page":"235","volume":"4","year":"1990","unstructured":"Wdzieczak-Bakala J, Fache MP, Lenfant M, et al. AcSDKP, an inhibitor of CFU-S proliferation is synthesized in mice under steady-state conditions and secreted by bone marrow in long term culture. Leukemia. 1990;4:235\u2013237.","journal-title":"Leukemia"},{"key":"e_1_3_2_3_2","first-page":"753","volume":"3","year":"1989","unstructured":"Frindel E, Monpezat JP. The physiological role of the endogenous colony forming units-spleen (CFU-S) inhibitor acetyl-N-Ser-Asp-Lys-Pro (AcSDKP). Leukemia. 1989;3:753\u2013754.","journal-title":"Leukemia"},{"key":"e_1_3_2_4_2","first-page":"1077","volume":"17","year":"1989","unstructured":"Monpezat JP, Frindel E. Further studies on the biological activities of the CFU-S inhibitory tetrapeptide AcSDKP, I: the precise point of the cell cycle sensitive to AcSDKP: studies on the effect of AcSDKP on GM-CFC and on the possible involvement of T-lymphocytes in AcSDKP response. Exp Hematol. 1989;17:1077\u20131080.","journal-title":"Exp Hematol"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(90)90489-A"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(91)81062-D"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118484"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.8.3656"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.30.5.1015"},{"key":"e_1_3_2_10_2","first-page":"99","volume":"23","year":"1990","unstructured":"Lombard M-N, Sotty D, Wdzieczak-Bakala J, et al. In vivo effect of the tetrapeptide, N-acetyl-Ser-Asp-Lys-Pro, on the G1-S transition of rat hepatocytes. Cell Tissue Kinet. 1990;23:99\u2013103.","journal-title":"Cell Tissue Kinet"},{"key":"e_1_3_2_11_2","first-page":"1G","volume":"65","year":"1990","unstructured":"Weber KT, Janicki JS, Pick R, et al. Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertension. Am J Cardiol. 1990;65:1G\u20137G.","journal-title":"Am J Cardiol"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/res.64.6.2524288"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1994.1036"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(96)00158-7"},{"key":"e_1_3_2_15_2","unstructured":"Pardo Mindan FJ Panizo A. Alterations in the extracellular matrix of the myocardium in essential hypertension. Eur Heart J. 1993;14(suppl J):12\u201314."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)80793-0"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.96.11.4002"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119360"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.37.3.827"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1998.tb01020.x"},{"key":"e_1_3_2_21_2","first-page":"732","volume":"82","year":"1995","unstructured":"Cappelaere P, Hecquet B, Rolland F, et al. Randomized placebo trial of myeloprotection with goralatide in patients with squamous cell carcinoma of the upper respiratory and digestive tracts or esophagus, treated with a carboplatin-fluorouracil combination. Bull Cancer. 1995;82:732\u2013737.","journal-title":"Bull Cancer"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1853.x"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-2862(88)90022-2"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01680633"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2828(95)90359-3"},{"key":"e_1_3_2_26_2","first-page":"325","volume":"147","year":"1995","unstructured":"Cleutjens JP, Verluyten MJ, Smiths JF, et al. Collagen remodeling after myocardial infarction in the rat heart. Am J Pathol. 1995;147:325\u2013338.","journal-title":"Am J Pathol"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2828(86)80410-2"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1997.1980737.x"},{"key":"e_1_3_2_29_2","first-page":"982","volume":"291","year":"1999","unstructured":"Junot C, Nicolet L, Ezan E, et al. Effects of angiotensin-converting enzyme inhibition on plasma, urine, and tissue concentrations of hemoregulatory peptide Acetyl-Ser-Asp-Lys-Pro in rats. J Cardiovasc Pharmacol. 1999;291:982\u2013987.","journal-title":"J Cardiovasc Pharmacol"},{"key":"e_1_3_2_30_2","first-page":"1074","volume":"26","year":"1998","unstructured":"Rousseau-Plasse A, Wdzieczak-Bakala J, Lenfant M, et al. Lisinopril, an angiotensin I-converting enzyme inhibitor, prevents entry of murine hematopoietic stem cells into the cell cycle after irradiation in vivo. Exp Hematol. 1998;26:1074\u20131079.","journal-title":"Exp Hematol"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.11.3307.3307"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1996.0063"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/4.1.51"},{"key":"e_1_3_2_34_2","first-page":"395","volume":"122","year":"1993","unstructured":"Sun Y, Ratajska A, Zhou G, et al. Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone. J Lab Clin Med. 1993;122:395\u2013403.","journal-title":"J Lab Clin Med"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.98.6.535"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00944788"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0022-3565(24)38267-9","volume":"289","year":"1999","unstructured":"Junot C, Menard J, Gonzales M-F, et al. In vivo assessment of captopril selectivity of angiotensin I-converting enzyme inhibition: differential inhibition of acetyl-Ser-Asp-Lys-Pro and angiotensin I hydrolysis. J Pharmacol Exp Ther. 1999;289:1257\u20131261.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_2_38_2","first-page":"79","volume":"26","year":"1998","unstructured":"Suzuki A, Aizawa S, Araki S, et al. Enhanced engraftment of intravenously transplanted hematopoietic stem cells into bone marrow of irradiated mice treated with AcSDKP. Exp Hematol. 1998;26:79\u201383.","journal-title":"Exp Hematol"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/stem.5530110513"},{"key":"e_1_3_2_40_2","first-page":"685","volume":"11","year":"1989","unstructured":"Weir MR. The effects of enalapril on blood pressure, renal hemodynamics, and renal function. Clin Ther. 1989;11:685\u2013700.","journal-title":"Clin Ther"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.103.25.3136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T19:19:48Z","timestamp":1743362388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.103.25.3136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6,26]]},"references-count":40,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2001,6,26]]}},"alternative-id":["10.1161\/01.CIR.103.25.3136"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.103.25.3136","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6,26]]},"assertion":[{"value":"2000-12-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-02-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-06-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}